SCYNEXIS Inc at Ladenburg Thalmann Virtual Healthcare Conference Transcript
Good morning, everyone. This is Michael Higgins, Managing Director, senior biotech analyst here at Ladenburg Thalmann. Thank you for joining us for our virtual healthcare conference.
Our next company to present is SCYNEXIS, a company I have covered for many years. So pleased to have them present here at the conference again. Presenting for the Company is the Chief Financial Officer, Eric Francois.
Eric, thanks for joining us. I will let you take it away. We've got some time then towards the end for a fireside chat. So looking forward to that.
Well, wonderful. Thank you so much, Michael. Thank you to you and the entire team for inviting us. We are excited to be here. A very important moment for us as a Company, and so this conference is perfect timing, in a way, to showcase a little bit what we're up to, and of course SCYNEXIS and ibrexafungerp, our lead asset, which I will go over in a couple slides here to present the opportunity.
So
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
